GRK1 — Drug Target
All drugs that target GRK1 — marketed and clinical-stage. Includes 1 drug classes acting on this target.
Drug classes
Phase 3 pipeline (1)
- MIM-D3 Ophthalmic Solution · Mimetogen Pharmaceuticals USA, Inc. · small molecule · Ophthalmology
MIM-D3 Ophthalmic Solution is a small molecule that targets the rhodopsin kinase (GRK1) to treat retinal diseases.